Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Erenumab migraine drug fails to meet NICE recommendation standards

europeanpharmaceuticalreviewSeptember 27, 2019

Tag: erenumab , Migraine , Drug , NICE

PharmaSources Customer Service